Article
A two-stage case-control association study of PADI2 with schizophrenia.
Journal of human genetics - 1 Jul 2009
Watanabe Yuichiro, Nunokawa Ayako, Kaneko Naoshi, Arinami Tadao, Ujike Hiroshi, Inada Toshiya, Iwata Nakao, Kunugi Hiroshi, Itokawa Masanari, Otowa Takeshi, Ozaki Norio, Someya Toshiyuki
Abstract excerpt
Peptidylarginine deiminases (PADIs), five isoforms of which have been identified, catalyze the conversion of arginine residues to citrulline residues in proteins. Recent studies have revealed that abnormal activation of PADI2, the gene for which is expressed throughout the nervous system, is likely to be related to the pathogenesis of neuropsychiatric diseases with neurodegenerative processes, such as Alzheimer's...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
